Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Steven Leeder

Showing results (71-80 of 191) with videos related to

Pageof 20
Sort By:
European Journal of Clinical Pharmacology|June 8, 2019
A population pharmacokinetic model for simvastatin and its metabolites in children and adolescentsKayode Ogungbenro, Jonathan B Wagner, Susan Abdel-Rahman, et al.
Journal of Clinical Pharmacology|February 13, 2010
Understanding the relative roles of pharmacogenetics and ontogeny in pediatric drug development and regulatory scienceJ Steven Leeder, Gregory L Kearns, Stephen P Spielberg, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 14, 2017
Age-dependent Protein Abundance of Cytosolic Alcohol and Aldehyde Dehydrogenases in Human LiverDeepak Kumar Bhatt, Andrea Gaedigk, Robin E Pearce, et al.
British Journal of Clinical Pharmacology|March 15, 2011
Developmental variations in metabolic capacity of flavin-containing mono-oxygenase 3 in childhoodMakiko Shimizu, Travis Denton, Marie Kozono, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 3, 2021
The Impact of Age and Genetics on Naltrexone BiotransformationStephani L Stancil, Whitney Nolte, Robin E Pearce, et al.
Journal of Clinical Pharmacology|May 31, 2013
Age related changes in fractional elimination pathways for drugs: assessing the impact of variable ontogeny on metabolic drug-drug interactionsFarzaneh Salem, Trevor N Johnson, Zoe E Barter, et al.
Pharmacogenomics|December 19, 2009
CYP2D7-2D6 hybrid tandems: identification of novel CYP2D6 duplication arrangements and implications for phenotype predictionAndrea Gaedigk, Uwe Fuhr, Charlene Johnson, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 8, 2016
Characterization of Atomoxetine Biotransformation and Implications for Development of PBPK Models for Dose Individualization in ChildrenJean C Dinh, Robin E Pearce, Leon Van Haandel, et al.
Birth Defects Research. Part A, Clinical and Molecular Teratology|January 31, 2008
Interindividual variability in acetaminophen sulfation by human fetal liver: implications for pharmacogenetic investigations of drug-induced birth defectsAraba A Adjei, Andrea Gaedigk, Stephen D Simon, et al.
Journal of Clinical Pharmacology|June 17, 2004
Comparison of various urine collection intervals for caffeine and dextromethorphan phenotyping in childrenMary Jayne Kennedy, Susan M Abdel-Rahman, Angela D M Kashuba, et al.
Pageof 20

Showing results (71-80 of 191) with videos related to

Sort By:
Pageof 20
European Journal of Clinical Pharmacology|June 8, 2019
A population pharmacokinetic model for simvastatin and its metabolites in children and adolescentsKayode Ogungbenro, Jonathan B Wagner, Susan Abdel-Rahman, et al.
Journal of Clinical Pharmacology|February 13, 2010
Understanding the relative roles of pharmacogenetics and ontogeny in pediatric drug development and regulatory scienceJ Steven Leeder, Gregory L Kearns, Stephen P Spielberg, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 14, 2017
Age-dependent Protein Abundance of Cytosolic Alcohol and Aldehyde Dehydrogenases in Human LiverDeepak Kumar Bhatt, Andrea Gaedigk, Robin E Pearce, et al.
British Journal of Clinical Pharmacology|March 15, 2011
Developmental variations in metabolic capacity of flavin-containing mono-oxygenase 3 in childhoodMakiko Shimizu, Travis Denton, Marie Kozono, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 3, 2021
The Impact of Age and Genetics on Naltrexone BiotransformationStephani L Stancil, Whitney Nolte, Robin E Pearce, et al.
Journal of Clinical Pharmacology|May 31, 2013
Age related changes in fractional elimination pathways for drugs: assessing the impact of variable ontogeny on metabolic drug-drug interactionsFarzaneh Salem, Trevor N Johnson, Zoe E Barter, et al.
Pharmacogenomics|December 19, 2009
CYP2D7-2D6 hybrid tandems: identification of novel CYP2D6 duplication arrangements and implications for phenotype predictionAndrea Gaedigk, Uwe Fuhr, Charlene Johnson, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 8, 2016
Characterization of Atomoxetine Biotransformation and Implications for Development of PBPK Models for Dose Individualization in ChildrenJean C Dinh, Robin E Pearce, Leon Van Haandel, et al.
Birth Defects Research. Part A, Clinical and Molecular Teratology|January 31, 2008
Interindividual variability in acetaminophen sulfation by human fetal liver: implications for pharmacogenetic investigations of drug-induced birth defectsAraba A Adjei, Andrea Gaedigk, Stephen D Simon, et al.
Journal of Clinical Pharmacology|June 17, 2004
Comparison of various urine collection intervals for caffeine and dextromethorphan phenotyping in childrenMary Jayne Kennedy, Susan M Abdel-Rahman, Angela D M Kashuba, et al.
Pageof 20